Test device for heart failure symptoms in some patients
Part of Heart & circulation clinical trials.
This study tests whether a heart-related device called CCM can improve symptoms and daily function in people with heart failure and a moderately reduced pumping strength. It may help if you’ve had recent heart-failure-related hospital care or urgent treatment and your heart and overall health fit the study limits.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign a consent form and are 18 or older (men or non-pregnant women).
- You have symptomatic heart failure and your echocardiogram shows pumping strength (LVEF) between 40% and 70%.
- In the past year you either had a heart-failure hospitalization, or in the past 6 months you had an urgent visit needing IV treatment; if not, special blood test results must be high enough.
- Your heart rhythm and vitals must meet limits: resting heart rate 50–110 bpm and resting blood pressure systolic 100–159.
- Your body size and heart valves must be acceptable: BMI 46 or less, and no severe valve narrowing or leaking; also no mechanical tricuspid valve or complex congenital heart disease.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational medicine called EDG-15400 for people with a type of heart failure where the heart muscle is stiff and doesn't relax properly, even though the pumping function is normal. The goal is to see if the medicine improves symptoms and daily functioning.
This study tests a heart device (CCM) plus standard medications to see if the combination helps people with a weak heart pump. It's for those whose heart function is low and who still have symptoms despite current treatment.
This study tests whether a CardioPulmonary Management (CPM) system device used at home is safe and can improve outcomes for people with chronic heart failure. It may help manage symptoms and reduce complications, especially for higher-risk patients.
This study tests a remote monitoring device that sends information to your care team to help adjust your heart failure medications. It aims to improve your condition after a hospital stay for heart failure.
This trial tests if a combination of a tiny lung-artery pressure sensor (CardioMEMS) and a mechanical heart pump (HeartMate 3) is safe and effective for people with advanced heart failure. If you qualify, you'll either get the heart pump plus standard medical therapy, or continue with standard therapy alone and have your pressure monitored remotely.
This study checks how safe a small heart-pressure monitoring device is for people with advanced heart failure and severe kidney problems. It looks at whether doctors can continuously track heart filling/pressure to help manage symptoms and reduce risks.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.